StockData
BioAge Labs, Inc. logo

BioAge Labs, Inc. (BIOA) stock

BIOANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$5.10−0.12 (-2.30%)

Close on Nov 17, 2026Market cap $234.07MP/E –Yield –

BioAge Labs operating margin

Operating margin is operating income as a percentage of revenue.

BioAge Labs's operating margin for the twelve months ending Jun 30, 2026 was -1026.3%. For fiscal 2025 it was -1031.5%.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-1031.5%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-1196.8%−169.8
Q1 FY2026Mar 31, 2026-915.4%+218.0
Q4 FY2025Dec 31, 2025-923.4%–
Q3 FY2025Sep 30, 2025-1126.6%–
Q2 FY2025Jun 30, 2025-1027.0%–
Q1 FY2025Mar 31, 2025-1133.4%–

More BioAge Labs figures

See a number that looks wrong?